SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severityKevin H. Toomer, Ivo M.B. Francischetti, Yifan Zhang et al.|eJHaem|2023Cited by 15